Prognostic evaluation of breast cancer in cytologic specimens

Analytical and Quantitative Cytology and Histology

Volumn 24, Issue 1, 2002, Pages 49-53

  Klorin, Geula ^a   Keren, Ruth ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Breast neoplasms; c erbB2; Estrogen receptor; Ki 67 antigen; p53 genes; Progesterone receptors; Prognosis

Indexed keywords

BIOLOGICAL MARKER; ESTROGEN; ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROGESTERONE; PROGESTERONE RECEPTOR; PROTEIN P53; STEROID RECEPTOR;

ADULT; ANEUPLOIDY; ARTICLE; ASPIRATION BIOPSY; BREAST CANCER; BREAST TUMOR; CONTROLLED STUDY; CYTODIAGNOSIS; DIAGNOSTIC TEST; DIPLOIDY; DNA CONTENT; FEMALE; FEULGEN STAINING; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOASSAY; IMMUNOCHEMISTRY; MAJOR CLINICAL STUDY; ONCOGENE C ERB; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; TETRAPLOIDY; TUMOR SUPPRESSOR GENE;

BIOPSY, NEEDLE; BREAST NEOPLASMS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; PLOIDIES; PROGNOSIS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036175023     PISSN: 08846812     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Prognosis and prediction of response in breast cancer: The current role of the main biological markers
2. Quantitative changes in cytological molecular markers during primary medical treatment of breast cancer: A pilot study
3. The relationship between prognostic and predictive factors in the management of breast cancer
4. Expression of epidermal growth factor receptor and c-erbB2 during the development of tamoxifen resistance in human breast cancer
5. Biologic markers as predictors of clinical outcome from systemic therapy for primary operable breast cancer
6. C-erb B2 overexpression decreases the benefit of adjuvant tamoxifen in early stage breast cancer without axillary lymph node metastases
7. C-erbB-2 oncoprotein detected by automated quantitative immunocytochemistry in breast carcinomas correlates with patients' overall and disease free survival
8. Predictive value of estrogen receptors evaluated by quantitative immunohistochemical analysis in breast cancer
9. Ki-67 immunostaining in 322 primary breast cancers: Association with clinical and pathological variables and prognosis
10. Microsatellite instability correlates with reduced survival and poor disease prognosis in breast cancer
11. Cytological evaluation of biological prognostic markers from primary breast carcinomas
12. Application of quantitative analysis to biologic profile evaluation in breast cancer
13. Her-2/neu oncogene expression, DNA ploidy, and proliferation index in breast cancer
14. Equipment, standardization, and application of image processing
15. Immunohistochemical tumor markers in infiltrating ductal breast carcinoma
16. DNA grading of malignancy in breast cancer: Prognostic validity reproducibility and comparison with other classifications
17. Mutant p53 expression and DNA analysis in human breast cancer: Comparison with conventional clinicopathological parameters
18. C-erbB-2, p53 protein expression and steroid hormone receptors in breast carcinoma: An immunohistochemical study
19. p53 in breast cancer: Its relation to histological grade, lymph-node status, hormone receptors, cell-proliferation fraction (ki-67) and c-erbB-2: Immunohistochemical study of 153 cases
20. Immunohistochemical evaluation of multiple biological markers in ductal carcinoma in situ of the breast
21. Prognostic significance of C-erbB-2 and hormone receptors' status in human benign and malignant breast lesions